Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence

Wei Pana Department of Clinical Laboratory, Haiyan People’s Hospital, Haiyan, Zhejiang, ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-2638-4615 View further author information

Diao Yub Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, ChinaView further author information

Na Shic Department of Clinical Laboratory, Second Sanatorium of Air Force Healthcare Center for Special Services, Hangzhou, Zhejiang, ChinaView further author information

Zheng Baod Department of Clinical Laboratory, Xiangshan Red Cross Taiwan Compatriot Hospital, Xiangshan, Zhejiang, ChinaView further author information

References

Nomura J, Seki M, Abe S, Kobayashi T, Okitsu Y, Fukuhara N, Takahashi, S, Harigae, H, Kameoka, J. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine. Hum Vaccin Immunother. 2023;19:2165381. doi:10.1080/21645515.2023.2165381.
PubMed Web of Science ®Google Scholar
Severance TS, Rahim MQ, French J, 2nd, Baker RM, Shriner A, Khaitan A, Overholt, KM. COVID-19 and hereditary spherocytosis: a recipe for hemolysis. Pediatr Blood Cancer. 2021;68:e28548. doi:10.1002/pbc.28548.
PubMed Web of Science ®Google Scholar
D’Aloisio R, Nasillo V, Gironi M, Mastropasqua R. Bilateral macular hemorrhage in a patient with COVID-19. Am J Ophthalmol Case Rep. 2020;20:100958. doi:10.1016/j.ajoc.2020.100958.
PubMedGoogle Scholar
Barberá-Pérez PM, Baquedano Lobera I, Paúl-Vidaller PJ. Haemolytic anemia triggered by SARS-CoV-2 in patient with hereditary spherocytosis. Med Clin. 2021;157:e304–2. doi:10.1016/j.medcle.2021.03.014.
PubMed Web of Science ®Google Scholar
Chen J, Cai W, Liu T, Zhou Y, Jin Y, Yang Y, Chen S, Tang K, Li C. The COVID-19 vaccine: attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases. Rheumatol Autoimmun. 2022;2:82–91. doi:10.1002/rai2.12028.
PubMedGoogle Scholar

Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date